trial

Evaluation of the H1-coil Deep TMS in the Treatment of Negative Symptoms and Cognitive Deficit in Schizophrenia

NCTId NCT00445926
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
Phase 1 · Completed
Enrollment —
Sponsored by Shalvata Mental Health Center
Primary completion 2009-05
Synthesized from structured facts only — each point cited above.

Design & status

Phase
Phase 1
Status
Completed
Enrollment
—
Study type
Interventional
Allocation
Non Randomized
Model
Single Group
Masking
None
Start
2006-07
Primary completion
2009-05
Eligibility
ALL · 18 Years · 65 Years

Interventions & indications

Drugs
deep TMS H-coil

Sponsors

Shalvata Mental Health CenterLead Sponsor

Investigators

1
Eiran V Harel, MDPrincipal Investigator

Sites

1 total
Hod HaSharon, Israel

Facts & assertions

3 sourced
Phase
PHASE1
Primary Completion Date
2009-05
Status
COMPLETED
relationships
The graph out of here
drug
deep TMS H-coil
drug
lead_sponsor
Shalvata Mental Health Center
company
indication
Schizophrenia
indication
Schizophrenia
indication
investigator
Eiran V Harel, MD
person